Artemis Medicare Services Management
Management criteria checks 2/4
Artemis Medicare Services' CEO is Devlina Chakravarty, appointed in Jan 2014, has a tenure of 10.92 years. total yearly compensation is ₹183.34M, comprised of 35.3% salary and 64.7% bonuses, including company stock and options. directly owns 2.57% of the company’s shares, worth ₹1.10B. The average tenure of the management team and the board of directors is 4.5 years and 7.1 years respectively.
Key information
Devlina Chakravarty
Chief executive officer
₹183.3m
Total compensation
| CEO salary percentage | 35.3% |
| CEO tenure | 10.9yrs |
| CEO ownership | 2.6% |
| Management average tenure | 4.5yrs |
| Board average tenure | 7.1yrs |
Recent management updates
Recent updates
Artemis Medicare Services Limited Recorded A 5.3% Miss On Revenue: Analysts Are Revisiting Their Models
Nov 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now
Jul 18Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce
Jul 16After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar
Apr 13Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Jun 14Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Mar 15Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal
Aug 31Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Jul 30Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return
May 13Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture
Jan 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Dec 10There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
Sep 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Jul 01There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
May 11We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt
Mar 16Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?
Jan 22Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Nov 13Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)
Jul 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹647m |
| Jun 30 2024 | n/a | n/a | ₹560m |
| Mar 31 2024 | ₹183m | ₹65m | ₹491m |
| Dec 31 2023 | n/a | n/a | ₹456m |
| Sep 30 2023 | n/a | n/a | ₹445m |
| Jun 30 2023 | n/a | n/a | ₹400m |
| Mar 31 2023 | ₹139m | ₹46m | ₹386m |
| Dec 31 2022 | n/a | n/a | ₹412m |
| Sep 30 2022 | n/a | n/a | ₹373m |
| Jun 30 2022 | n/a | n/a | ₹363m |
| Mar 31 2022 | ₹49m | ₹46m | ₹318m |
| Dec 31 2021 | n/a | n/a | ₹313m |
| Sep 30 2021 | n/a | n/a | ₹301m |
| Jun 30 2021 | n/a | n/a | ₹221m |
| Mar 31 2021 | ₹51m | ₹48m | ₹65m |
| Dec 31 2020 | n/a | n/a | -₹19m |
| Sep 30 2020 | n/a | n/a | -₹16m |
| Jun 30 2020 | n/a | n/a | ₹38m |
| Mar 31 2020 | ₹52m | ₹48m | ₹198m |
Compensation vs Market: Devlina's total compensation ($USD2.14M) is above average for companies of similar size in the Indian market ($USD266.97K).
Compensation vs Earnings: Devlina's compensation has increased by more than 20% in the past year.
CEO
Devlina Chakravarty (56 yo)
10.9yrs
Tenure
₹183,337,000
Compensation
Dr. Devlina Chakravarty, M.D., DNB, DMRD, Radiolog,y serves as Chief Executive Officer at Artemis Medicare Services Limited and its Managing Director and Executive Director since February 2, 2015. Dr. Chak...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 10.9yrs | ₹183.34m | 2.57% ₹ 1.1b | |
| Chief Financial Officer | no data | ₹8.63m | no data | |
| Company Secretary & Compliance Officer | 2.1yrs | ₹4.24m | no data | |
| Chief-Strategy | no data | no data | no data | |
| Head of Legal | no data | no data | no data | |
| Chief People Officer of Human Resources & Training | no data | no data | no data | |
| Chief Medical Services & Chairperson of Nephrology | 4.5yrs | no data | no data |
4.5yrs
Average Tenure
Experienced Management: ARTEMISMED's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 9.7yrs | ₹183.34m | 2.57% ₹ 1.1b | |
| Non-Executive Non-Independent Chairman | 18.3yrs | ₹400.00k | 0.0036% ₹ 1.6m | |
| Non-Executive & Non-Independent Director | 16.9yrs | ₹480.00k | no data | |
| Independent Director | less than a year | no data | no data | |
| Non-Executive & Non-Independent Director | 10.8yrs | ₹2.92m | no data | |
| Independent Director | less than a year | ₹180.00k | no data | |
| Non-Executive Independent Woman Director | 4.6yrs | ₹540.00k | no data | |
| Non-Executive Independent Director | 3.6yrs | ₹520.00k | no data | |
| Independent Director | 4.3yrs | ₹460.00k | no data | |
| Non-Executive & Non-Independent Director | 17.9yrs | ₹480.00k | no data |
7.1yrs
Average Tenure
62.5yo
Average Age
Experienced Board: ARTEMISMED's board of directors are considered experienced (7.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 04:39 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Artemis Medicare Services Limited is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sumit Gupta | Centrum Broking Limited |